011000 — Gene One Life Science Income Statement
0.000.00%
Last trade - 00:00
- KR₩186bn
- KR₩193bn
- KR₩40bn
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 41,241 | 41,503 | 38,700 | 48,718 | 40,203 |
Cost of Revenue | |||||
Gross Profit | 12,889 | 11,412 | 8,757 | 9,336 | -7,759 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 49,298 | 59,396 | 65,117 | 88,768 | 122,258 |
Operating Profit | -8,057 | -17,893 | -26,416 | -40,050 | -82,055 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -7,145 | -18,226 | -15,534 | -38,054 | -77,655 |
Provision for Income Taxes | |||||
Net Income After Taxes | -7,619 | -18,648 | -15,888 | -38,150 | -77,768 |
Net Income Before Extraordinary Items | |||||
Net Income | -7,619 | -18,648 | -15,888 | -38,150 | -77,768 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -7,619 | -18,648 | -15,888 | -38,150 | -77,768 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -187 | -260 | -222 | -493 | -719 |
Dividends per Share |